Powered by Smartsupp

Gut microbiome tests: what do they show and are they useful?

KINGRAY ACADEMY · DIGESTION AND GUT HEALTH · 06

Can a gut microbiome test identify the cause of digestive symptoms?

A test can describe microorganisms or their genetic material in a sample and compare the findings with a laboratory reference. A standard commercial profile cannot, on its own, diagnose a condition or identify someone’s ideal diet or probiotic. [1]

We explain testing methods, percentages and diversity, and distinguish microbiome profiling from targeted medical investigations. A practical checklist helps you consider whether a test answers a useful question.

Author: Ing. František Kokoš – nutrition adviserUpdated:
Illustration of the gut, microorganisms and foods
AI-generated illustration. Not a laboratory result or an exact anatomical depiction.

What does microbiome analysis actually measure?

The digestive tract contains bacteria, viruses, fungi and other microorganisms. Microbiota refers to the community; microbiome also encompasses genetic information and the wider environment. There is no single bacterium or unchanging “healthy template”. Microorganisms process some dietary components and produce metabolites.

For a typical stool profile, the laboratory processes a small sample and identifies microbial features according to its method. This is not a direct view of every gut region. It does not automatically measure intestinal mucus, nutrient absorption or the actual production of every metabolite.

[1]

↑ Back to article contents

How do 16S sequencing and shotgun metagenomics differ?

16S rRNA gene sequencing

This targets selected regions of a marker gene, mainly in bacteria and archaea. Resolution depends on the region, method and database; results often cannot reliably identify a particular strain.

Shotgun metagenomics

This examines a broader range of DNA in the sample and may provide more detailed taxonomic and gene information. Detecting a gene does not establish its current activity or a clinical effect.

Targeted PCR or culture may answer a specific diagnostic question but are not automatically comprehensive microbiome profiles. Calling a method “advanced” does not by itself demonstrate that its result will help with your decision.

[1]

↑ Back to article contents

How should you read percentages, diversity and coloured scores?

Relative abundance is a share of the sample, not a count of bacteria throughout the gut. A change in one group can change another group’s percentage even if its absolute amount stays the same.

Illustrative example: a simplified sample contains 10 units of group A and 90 other units, so A accounts for 10%. If A stays at 10 while the others fall to 40, A accounts for 20%. The percentage doubled; the amount of A did not. This explains the calculation and is not a patient result.

Alpha diversity describes diversity within a sample; beta diversity describes differences between samples. Interpretation depends on age, method and context. A departure from a laboratory reference or a “dysbiosis” score does not independently diagnose disease or measure its severity.

[1] [7]

↑ Back to article contents

Is microbiome profiling the same as a medical stool test?

No. A targeted medical investigation may look for a particular pathogen, bleeding or evidence of inflammation. The choice follows symptoms and the clinician’s question. Profiling microbial composition serves a different purpose; a negative or favourable-looking profile does not rule out all disease.

  • SIBO: bacterial proportions in stool do not by themselves demonstrate overgrowth in the small intestine.
  • Coeliac disease and allergy: a standard commercial microbiome profile cannot diagnose these.
  • IBS: assessment uses symptoms, history and, when needed, investigations for other causes.

The label “stool test” is therefore insufficient. Ask about the exact test, method and indication.

[1] [5]

↑ Back to article contents

Why can two laboratories produce different reports?

Collection, storage, transport, DNA extraction, sequencing, databases and computational analysis all matter. The person also changes: food, infections, medicines and gut transit time can influence the sample.

NIST compared seven commercial services using standardised material and found substantial differences both within and between services. This highlights the need for quality control and standardisation; it does not establish that every test is worthless.

Follow the collection kit’s instructions. Do not stop medicines or substantially alter your usual diet simply to obtain a “better” result unless your treating professional advises it. Repeat tests from different laboratories may not be directly comparable.

[1] [4]

↑ Back to article contents

Can a test choose the right probiotic or diet?

A bacterial percentage alone is not a reliable instruction to replace a “missing” species. Probiotic evidence depends on genus, species and strain, intended use, dose, duration and the population studied. More CFU does not automatically mean a better result; storage and declared viability matter too.

Not all fermented foods contain defined probiotic strains. Serious illness or substantial immune impairment requires professional advice about probiotic use. Dietary changes should account for symptoms, diagnosis, tolerance and nutritional needs, rather than only a coloured bar on a report.

[2] [3]

↑ Back to article contents

What should you ask before ordering a test?

  1. What specific question should this investigation answer?
  2. Is clinical usefulness established for that purpose, or does it mainly describe a sample?
  3. Which method and reference group are used, and how is quality checked?
  4. Will the result change the next step, and who will interpret it?
  5. What is the total cost, including recommended repeats and consultations?

Also check data protection and whether the same provider sells recommended preparations. A commercial relationship does not automatically invalidate a service, but it should be clear. International consensus does not support widespread routine profiling without sufficient evidence of benefit.

[1] [4]

↑ Back to article contents

When should medical care come first, and what can you do meanwhile?

Persistent symptoms, unexplained weight loss, blood in the stool or suspected anaemia need medical assessment. Severe pain, substantial bleeding, fainting or marked dehydration require urgent help. Do not wait for a commercial report.

For everyday care, record meals, symptoms, medicines and bowel movements. Adapt a varied diet and fibre from different plant sources to your tolerance, increasing it gradually. With diagnosed disease or substantial bloating, plan changes with a professional. You do not need an “ideal” microbiome score before establishing sensible dietary habits.

[5] [6] [8]

↑ Back to article contents

In plain language

A test describes a sample. A clinician assesses the person and their symptoms. An attractive graph or an unusual percentage does not by itself identify a disease or the preparation you need.

[1] [2]

↑ Back to article contents

Frequently asked questions

Can a microbiome test explain bloating?

Not reliably on its own. Bloating has several possible causes; a clinician considers symptoms, diet, medicines and any appropriate targeted investigations.

[1] [5]

Is low microbiome diversity a diagnosis?

No. It is a measure that depends on method and context, not a standalone diagnosis or treatment prescription.

[1]

Does twice the percentage mean twice as many bacteria?

Not necessarily. Relative proportions depend on other groups too. Without an absolute measurement, that conclusion is not justified.

[1] [7]

Can I choose a probiotic from the result?

The profile alone cannot reliably select one. The strain, clinical purpose, dose, age and health status must be considered.

[1] [2] [3]

Are all stool tests unreliable?

No. Commercial microbiome profiles differ from targeted medical stool investigations with a specific indication.

[1] [5]

Should I stop medicines or change my diet before testing?

Not without advice from your treating professional. Follow collection instructions and report medicines and recent changes.

[1]

Scientific references

Numbers in the text refer to the sources below. This article explains research and its limits; it does not replace an individual assessment or treatment plan.

  1. Porcari et al. (2025): International consensus statement on microbiome testing in clinical practice
  2. NIH Office of Dietary Supplements: Probiotics — Fact Sheet for Health Professionals
  3. NCCIH: Probiotics — Usefulness and Safety
  4. Servetas et al. (2024), NIST: Evaluating the analytical performance of direct-to-consumer gut microbiome testing services
  5. NIDDK: Diagnosis of Irritable Bowel Syndrome
  6. NHS: Symptoms of IBS
  7. Gloor et al. (2017): Microbiome Datasets Are Compositional: And This Is Not Optional
  8. NIDDK: Constipation — Eating, Diet, & Nutrition

Ing. František Kokoš
Author: Ing. František Kokoš
Ing. František Kokoš – Author of KINGRAY Academy and Advice Corner
Technician, nutrition adviser (graduate of the 150-hour Welko retraining programme, 2025) and creator of the KINGRAY nutraceuticals concept. Years of developing the BIOquant medical device and working with blood rheology and tissue oxygenation led him to realise that bodily health requires the full picture – linking microcirculation, cellular energy and proper nutrition. In his articles, he looks for the balance where the body understands and cooperates with us.
He is the author of the book Liečba svetlom (Light Therapy, ISBN 978-80-970512-0-4), co-author of the publication BIOquant – polovodičová laserová terapia (BIOquant – Semiconductor Laser Therapy, ISBN 978-80-970512-2-8), and originator of patents in light technologies (US9731145B2, SK5457Y1).
%s ...
%s
%image %title %code %s
%s